The Longevity Fund

Investor type

VC

Founded

2011

AUM

$37 M

Location

United States

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Seed

Investment Stage

IPO

Exit Strategy

Investor profile last updated: 01 February, 2026

Profile

In the 20th century, we learned that healthy lifespan is malleable. The scientific pathways behind this effect are incredibly complex and difficult to correctly control, but manipulating them may lead to new treatments for age-related disease. We want to get these therapeutic advances translated safely to patients as quickly as possible. Longevity Fund companies have collected >$500M in follow-on funding, resulting in the 2018 IPO of the first company dedicated to reversing the diseases of aging, and multiple programs in clinic to reverse or prevent age-related disease.


Industry

Biotechnology Financial Services Healthcare Services

Region of investment

North America

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
W8p5GeARHNjUtlh7 W8p5GeARHNjUtlh7
W8p5GeARHNjUtlh7
avatar
W8p5GeARHNjUtlh7 W8p5GeARHNjUtlh7
W8p5GeARHNjUtlh7
avatar
W8p5GeARHNjUtlh7 W8p5GeARHNjUtlh7
W8p5GeARHNjUtlh7
avatar
W8p5GeARHNjUtlh7 W8p5GeARHNjUtlh7
W8p5GeARHNjUtlh7
avatar
W8p5GeARHNjUtlh7 W8p5GeARHNjUtlh7
W8p5GeARHNjUtlh7
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about The Longevity Fund

The Longevity Fund is located in United States.
The Longevity Fund was founded in 2011.
The Longevity Fund invests in companies and startups in Biotechnology, Financial Services, Healthcare Services.
The Longevity Fund invests in companies and startups in North America.
The Longevity Fund invests in companies and startups at Seed.
The Longevity Fund usually invests $1-5 m on average.
The Longevity Fund has around $37m assets under management.